News & Updates
Filter by Specialty:
Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo
27 Jan 2023
Treatment with oral ritlecitinib improves outcomes in patients with active nonsegmental vitiligo, without any serious adverse events over 48 weeks, results of a study have shown.
Oral ritlecitinib safe, effective for treatment of active nonsegmental vitiligo
27 Jan 2023
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes
26 Jan 2023
Women with nonalcoholic fatty liver disease (NAFLD), despite having a normal weight, remains at greater risk of adverse pregnancy outcomes, reveals a study.
NAFLD, regardless of obesity status, ups risk of adverse pregnancy outcomes
26 Jan 2023
Online on par with in-person care for improving outcomes in psoriasis
26 Jan 2023
An online health model appears to be as effective as in-person care for decreasing functional impairment and depressive symptoms in patients with psoriasis, according to a study.
